A detailed history of Mizuho Securities Usa LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mizuho Securities Usa LLC holds 131,466 shares of BMY stock, worth $7.59 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
131,466
Previous 301,844 56.45%
Holding current value
$7.59 Million
Previous $15.6 Million 56.45%
% of portfolio
0.16%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $6.76 Million - $8.82 Million
-170,378 Reduced 56.45%
131,466 $6.8 Million
Q3 2024

Nov 06, 2024

BUY
$39.66 - $51.75 $5.77 Million - $7.53 Million
145,551 Added 93.13%
301,844 $15.6 Million
Q2 2024

Jul 31, 2024

BUY
$40.25 - $52.99 $6.29 Million - $8.28 Million
156,293 New
156,293 $6.49 Million
Q3 2020

Oct 26, 2020

SELL
$57.43 - $63.64 $261,708 - $290,007
-4,557 Closed
0 $0
Q2 2020

Jul 27, 2020

BUY
$54.82 - $64.09 $249,814 - $292,058
4,557 New
4,557 $268,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mizuho Securities Usa LLC Portfolio

Follow Mizuho Securities Usa LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mizuho Securities Usa LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mizuho Securities Usa LLC with notifications on news.